RxDoctor Payments Data

Maggi Ormand, PA

Physician Assistant · Asheville, NCNPI 1497022305

Payments from drug & device makers

$11,165in general payments, 2019–2025

Across 594 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$939
  • Lilly USA, LLC$902
  • Novo Nordisk$710
  • AstraZeneca$627
  • Abbott$532
  • plus $5K from 41 others

What the payments were for

  • Food & beverage$11,165100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,165 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$48,649
Medicare patients
142
Services billed
736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$47,763
OzempicSemaglutide20$30,658
XareltoRivaroxaban26$29,591
VraylarCariprazine Hcl17$23,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$16,173
LinzessLinaclotide17$14,571
JardianceEmpagliflozin22$11,610
FarxigaDapagliflozin Propanediol12$11,443
KerendiaFinerenone12$11,413
Spiriva RespimatTiotropium Bromide11$5,840
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,340
ShingrixVaricella-Zoster Ge/As01b/Pf20$4,503
Dexlansoprazole DrDexlansoprazole16$3,562
SynthroidLevothyroxine Sodium26$1,946
Albuterol Sulfate HfaAlbuterol Sulfate76$1,806

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$939$47,76348 claims
AbbVieVraylar, Linzess, Synthroid$2,039$40,20460 claims
Novo NordiskOzempic$710$30,65820 claims
Johnson & JohnsonXarelto$306$29,59126 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$241$22,79044 claims
GSKTrelegy Ellipta, Shingrix$315$20,67638 claims
AstraZenecaFarxiga$627$11,44312 claims
BayerKerendia$384$11,41312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →